Insulin Resistance and Alzheimer-like Reductions in Regional Cerebral Glucose Metabolism for Cognitively Normal Adults With Prediabetes or Early Type 2 Diabetes
LAURA BAKER
1
,
Donna J. Cross
2
,
SATOSHI MINOSHIMA
2
,
Dana Belongia
2
,
G. Stennis Watson
2
,
S. Craft
2
1
Geriatric Research, Education, and Clinical Center, Veterans Affairs Puget Sound Health Care System, Seattle, WA, USA. ldbaker@uw.edu
|
Publication type: Journal Article
Publication date: 2011-01-01
SJR: —
CiteScore: —
Impact factor: —
ISSN: 00039942, 15383687
PubMed ID:
20837822
Arts and Humanities (miscellaneous)
Neurology (clinical)
Abstract
Insulin resistance is a causal factor in prediabetes (PD) and type 2 diabetes (T2D) and increases the risk of developing Alzheimer disease (AD). Reductions in cerebral glucose metabolic rate (CMRglu) as measured by fludeoxyglucose F 18-positron emission tomography (FDG-PET) in parietotemporal, frontal, and cingulate cortices are associated with increased AD risk and can be observed years before dementia onset.To examine whether greater homeostasis model assessment insulin resistance (HOMA-IR) is associated with reduced resting CMRglu in areas vulnerable in AD in cognitively normal adults with newly diagnosed PD or T2D (PD/T2D), and to determine whether adults with PD/T2D have abnormal patterns of CMRglu during a memory encoding task.Randomized crossover design of resting and activation FDG-PET.University imaging center and Veterans Affairs clinical research unit.Twenty-three older adults (mean [SEM] age, 74.4 [1.4] years) with no prior diagnosis of diabetes but who met American Diabetes Association glycemic criteria for PD (n = 11) or diabetes (n = 12) based on fasting or 2-hour oral glucose tolerance test (OGTT) glucose values and 6 adults (mean [SEM] age, 74.3 [2.8] years) with normal fasting glucose values and glucose tolerance. No participant met Petersen criteria for mild cognitive impairment.Fasting participants underwent resting and cognitive activation FDG-PET imaging on separate days. Following a 30-minute transmission scan, subjects received an intravenous injection of 5 mCi of FDG, and the emission scan commenced 40 minutes after injection. In the activation condition, a 35-minute memory encoding task was initiated at the time of tracer injection. Subjects were instructed to remember a repeating list of 20 words randomly presented in series through earphones. Delayed free recall was assessed once the emission scan was complete.The HOMA-IR value was calculated using fasting glucose and insulin values obtained during OGTT screening and then correlated with CMRglu values obtained during the resting scan. Resting CMRglu values were also subtracted from CMRglu values obtained during the memory encoding activation scan to examine task-related patterns of CMRglu.Greater insulin resistance was associated with an AD-like pattern of reduced CMRglu in frontal, parietotemporal, and cingulate regions in adults with PD/T2D. The relationship between CMRglu and HOMA-IR was independent of age, 2-hour OGTT glucose concentration, or apolipoprotein E ε4 allele carriage. During the memory encoding task, healthy adults showed activation in right anterior and inferior prefrontal cortices, right inferior temporal cortex, and medial and posterior cingulate regions. Adults with PD/T2D showed a qualitatively different pattern during the memory encoding task, characterized by more diffuse and extensive activation, and recalled fewer items on the delayed memory test.Insulin resistance may be a marker of AD risk that is associated with reduced CMRglu and subtle cognitive impairments at the earliest stage of disease, even before the onset of mild cognitive impairment.
Found
Nothing found, try to update filter.
Found
Nothing found, try to update filter.
Top-30
Journals
|
2
4
6
8
10
12
14
16
18
20
|
|
|
Journal of Alzheimer's Disease
19 publications, 3.7%
|
|
|
International Journal of Molecular Sciences
15 publications, 2.92%
|
|
|
Frontiers in Neuroscience
14 publications, 2.72%
|
|
|
Diabetes
9 publications, 1.75%
|
|
|
Frontiers in Aging Neuroscience
9 publications, 1.75%
|
|
|
Diabetes Care
8 publications, 1.56%
|
|
|
Frontiers in Endocrinology
8 publications, 1.56%
|
|
|
Alzheimer's and Dementia
8 publications, 1.56%
|
|
|
Scientific Reports
7 publications, 1.36%
|
|
|
PLoS ONE
7 publications, 1.36%
|
|
|
Neurobiology of Aging
7 publications, 1.36%
|
|
|
Molecular Neurobiology
6 publications, 1.17%
|
|
|
Neuropharmacology
6 publications, 1.17%
|
|
|
Journal of Clinical Endocrinology and Metabolism
5 publications, 0.97%
|
|
|
Ageing Research Reviews
5 publications, 0.97%
|
|
|
Progress in Neurobiology
5 publications, 0.97%
|
|
|
Biochimica et Biophysica Acta - Molecular Basis of Disease
5 publications, 0.97%
|
|
|
Journal of Neurochemistry
5 publications, 0.97%
|
|
|
Journal of Clinical Medicine
4 publications, 0.78%
|
|
|
Frontiers in Neurology
4 publications, 0.78%
|
|
|
Neurochemical Research
4 publications, 0.78%
|
|
|
Neuroscience
4 publications, 0.78%
|
|
|
Neurobiology of Disease
4 publications, 0.78%
|
|
|
Human Brain Mapping
4 publications, 0.78%
|
|
|
International Review of Neurobiology
4 publications, 0.78%
|
|
|
BioMed Research International
3 publications, 0.58%
|
|
|
Journal of Cerebral Blood Flow and Metabolism
3 publications, 0.58%
|
|
|
Pharmaceuticals
3 publications, 0.58%
|
|
|
Metabolic Brain Disease
3 publications, 0.58%
|
|
|
2
4
6
8
10
12
14
16
18
20
|
Publishers
|
20
40
60
80
100
120
140
|
|
|
Elsevier
134 publications, 26.07%
|
|
|
Springer Nature
84 publications, 16.34%
|
|
|
Wiley
47 publications, 9.14%
|
|
|
Frontiers Media S.A.
41 publications, 7.98%
|
|
|
MDPI
41 publications, 7.98%
|
|
|
American Diabetes Association
17 publications, 3.31%
|
|
|
Taylor & Francis
16 publications, 3.11%
|
|
|
IOS Press
15 publications, 2.92%
|
|
|
Hindawi Limited
12 publications, 2.33%
|
|
|
SAGE
10 publications, 1.95%
|
|
|
The Endocrine Society
8 publications, 1.56%
|
|
|
Public Library of Science (PLoS)
7 publications, 1.36%
|
|
|
American Physiological Society
7 publications, 1.36%
|
|
|
Cold Spring Harbor Laboratory
6 publications, 1.17%
|
|
|
Ovid Technologies (Wolters Kluwer Health)
5 publications, 0.97%
|
|
|
Mary Ann Liebert
4 publications, 0.78%
|
|
|
Cambridge University Press
4 publications, 0.78%
|
|
|
Bentham Science Publishers Ltd.
3 publications, 0.58%
|
|
|
Oxford University Press
3 publications, 0.58%
|
|
|
IMR Press
3 publications, 0.58%
|
|
|
EDP Sciences
2 publications, 0.39%
|
|
|
F1000 Research
2 publications, 0.39%
|
|
|
Society of Nuclear Medicine
2 publications, 0.39%
|
|
|
AOSIS
2 publications, 0.39%
|
|
|
American Society for Nutrition
2 publications, 0.39%
|
|
|
Federation of American Societies for Experimental Biology (FASEB)
2 publications, 0.39%
|
|
|
American Society for Clinical Investigation
1 publication, 0.19%
|
|
|
American Society for Pharmacology and Experimental Therapeutics
1 publication, 0.19%
|
|
|
Canadian Science Publishing
1 publication, 0.19%
|
|
|
20
40
60
80
100
120
140
|
- We do not take into account publications without a DOI.
- Statistics recalculated weekly.
Are you a researcher?
Create a profile to get free access to personal recommendations for colleagues and new articles.
Metrics
514
Total citations:
514
Citations from 2024:
64
(12.45%)
Cite this
GOST |
RIS |
BibTex
Cite this
GOST
Copy
BAKER L. et al. Insulin Resistance and Alzheimer-like Reductions in Regional Cerebral Glucose Metabolism for Cognitively Normal Adults With Prediabetes or Early Type 2 Diabetes // Archives of Neurology. 2011. Vol. 68. No. 1.
GOST all authors (up to 50)
Copy
BAKER L., Cross D. J., MINOSHIMA S., Belongia D., Watson G. S., Craft S. Insulin Resistance and Alzheimer-like Reductions in Regional Cerebral Glucose Metabolism for Cognitively Normal Adults With Prediabetes or Early Type 2 Diabetes // Archives of Neurology. 2011. Vol. 68. No. 1.
Cite this
RIS
Copy
TY - JOUR
DO - 10.1001/archneurol.2010.225
UR - https://doi.org/10.1001/archneurol.2010.225
TI - Insulin Resistance and Alzheimer-like Reductions in Regional Cerebral Glucose Metabolism for Cognitively Normal Adults With Prediabetes or Early Type 2 Diabetes
T2 - Archives of Neurology
AU - BAKER, LAURA
AU - Cross, Donna J.
AU - MINOSHIMA, SATOSHI
AU - Belongia, Dana
AU - Watson, G. Stennis
AU - Craft, S.
PY - 2011
DA - 2011/01/01
PB - American Medical Association (AMA)
IS - 1
VL - 68
PMID - 20837822
SN - 0003-9942
SN - 1538-3687
ER -
Cite this
BibTex (up to 50 authors)
Copy
@article{2011_BAKER,
author = {LAURA BAKER and Donna J. Cross and SATOSHI MINOSHIMA and Dana Belongia and G. Stennis Watson and S. Craft},
title = {Insulin Resistance and Alzheimer-like Reductions in Regional Cerebral Glucose Metabolism for Cognitively Normal Adults With Prediabetes or Early Type 2 Diabetes},
journal = {Archives of Neurology},
year = {2011},
volume = {68},
publisher = {American Medical Association (AMA)},
month = {jan},
url = {https://doi.org/10.1001/archneurol.2010.225},
number = {1},
doi = {10.1001/archneurol.2010.225}
}